Health for all
Our medicines, vaccines and consumer healthcare products are improving quality of life for patients and consumers around the world.
But millions of people are still not getting the vaccines and treatments they need because they can’t afford them, they can’t get them locally, or they simply don’t exist. Many countries continue to have under-resourced health systems.
To play our part in tackling these global health challenges and extend the benefits of our products to more people, we are using open innovation to target unmet medical needs, pioneering new business models to increase access to our products and collaborating to strengthen healthcare infrastructure.
More about health for all
Access to healthcare
Tackling diseases in developing countries
We work to tackle some of the root causes of disease and contribute to healthier communities around the world
HIV, AIDS and ViiV Healthcare
Our priority is to develop new medicines for HIV/AIDS and ensure they can be accessed by the people who need them most
Health and well-being in communities
Our philosophy is to target support on selected health and educational programmes that are innovative, sustainable and produce tangible results
Reinvesting in healthcare
We have committed to reinvest 20% of our profits back in to improving the healthcare infrastructure in the world’s Least Developed Countries